2026 Q1 Portfolio Activity
In 2026 Q1, ALETHEA CAPITAL MANAGEMENT, LLC maintained a portfolio of 17 distinct positions. The most significant new addition was ATRIUM THERAPEUTICS INC, now representing 0.30% of the total fund value. They heavily accumulated shares in SPDR SERIES TRUST, increasing the position by 170.5%. Conversely, ALETHEA CAPITAL MANAGEMENT, LLC completely exited their position in AVIDITY BIOSCIENCES INC.
Position History
hover any row below to update
Loading…
Total Positions
17
Quarter
2026 Q1
Top Holding
AXSM (56.3%)
Top 10 Concentration
99.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-17 of 17
ALETHEA CAPITAL MANAGEMENT, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 56.28% | 59.30% |
#1
Prev: #1
|
6.5 |
—
|
-19,596 | -2.9% |
P
S
|
649,114 | $109,713,248 |
$11.50
+1937.0%
|
2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
BIL
SPDR SERIES TRU...
|
ETF | 30.09% | 10.50% |
#2
1
Prev: #3
|
8.5 |
—
|
403,427 | 170.5% |
P
S
|
640,038 | $58,653,085 |
$81.63
+12.2%
|
2018 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 6.38% | 7.18% |
#3
1
Prev: #4
|
5.6 |
—
|
106,687 | 7.5% |
P
S
|
1,529,369 | $12,433,770 |
$11.15
-6.7%
|
2016 Q2 | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
SPY
PUT
STATE STR SPDR ...
|
PUT Option | 4.50% | — |
#4
Prev: #—
|
5.8 |
—
|
13,500 | — |
NEW
|
13,500 | $8,779,590 | 2014 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TLT
ISHARES TR
|
ETF | 1.02% | 0.98% |
#5
1
Prev: #6
|
1.4 |
—
|
-292 | -1.3% |
P
S
|
22,831 | $1,979,219 | 2016 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 0.73% | 0.90% |
#6
1
Prev: #7
|
1.3 |
—
|
no change | no change |
P
S
|
31,554 | $1,426,872 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
N/A
ATRIUM THERAPEU...
|
|
Unknown | 0.30% | — |
#7
Prev: #—
|
3.6 |
—
|
43,758 | — |
NEW
|
43,758 | $585,044 | — | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
WFC
WELLS FARGO & C...
|
Financial Services | 0.25% | — |
#8
Prev: #—
|
3.6 |
—
|
6,030 | — |
NEW
|
6,030 | $480,048 | 2018 Q2 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
HEDJ
WISDOMTREE TR
|
ETF | 0.20% | 0.19% |
#9
Prev: #9
|
1.1 |
—
|
no change | no change |
P
S
|
7,430 | $388,589 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
GPK
GRAPHIC PACKAGI...
|
Consumer Cyclical | 0.08% | — |
#10
Prev: #—
|
3.5 |
—
|
16,330 | — |
NEW
|
16,330 | $162,320 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
SPY
STATE STR SPDR ...
|
ETF | 0.06% | 4.61% |
#11
6
Prev: #5
|
0.0 |
—
|
-13,737 | -98.6% |
P
S
|
190 | $123,565 | 2014 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
IMRX
IMMUNEERING COR...
|
Healthcare | 0.06% | 0.07% |
#12
1
Prev: #11
|
1.0 |
—
|
no change | no change |
P
S
|
22,935 | $120,867 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TGB
TASEKO MINES LT...
|
Basic Materials | 0.03% | 0.03% |
#13
1
Prev: #12
|
1.0 |
—
|
no change | no change |
P
S
|
10,000 | $64,500 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
LPRO
OPEN LENDING CO...
|
Financial Services | 0.01% | 0.01% |
#14
1
Prev: #13
|
1.0 |
—
|
no change | no change |
P
S
|
12,000 | $15,000 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
RSPU
INVESCO EXCHANG...
|
Unknown | 0.00% | 0.10% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-2,847 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
CDTX
CIDARA THERAPEU...
|
Unknown | 0.00% | 0.50% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-4,630 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 15.62% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-446,127 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 |
Showing 1-17 of 17 holdings